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Characterizing the genetic determinants of complex diseases can be further augmented by
incorporating knowledge of underlying structure or classifications of the genome, such as
newly developed mappings of protein-coding genes, epigenetic marks, enhancer elements
and non-coding RNAs.
Methods
We apply a simple class-level testing framework, termed Genetic Class Association Testing
(GenCAT), to identify protein-coding gene association with 14 cardiometabolic (CMD)
related traits across 6 publicly available genome wide association (GWA) meta-analysis
data resources. GenCAT uses SNP-level meta-analysis test statistics across all SNPs
within a class of elements, as well as the size of the class and its unique correlation struc-
ture, to determine if the class is statistically meaningful. The novelty of findings is evaluated
through investigation of regional signals. A subset of findings are validated using recently
updated, larger meta-analysis resources. A simulation study is presented to characterize
overall performance with respect to power, control of family-wise error and computational
efficiency. All analysis is performed using the GenCAT package, R version 3.2.1.
Results
We demonstrate that class-level testing complements the common first stage minP approach
that involves individual SNP-level testing followed by post-hoc ascribing of statistically signifi-
cant SNPs to genes and loci. GenCAT suggests 54 protein-coding genes at 41 distinct loci
for the 13 CMD traits investigated in the discovery analysis, that are beyond the discoveries
of minP alone. An additional application to biological pathways demonstrates flexibility in
defining genetic classes.
PLOS ONE | DOI:10.1371/journal.pone.0148218 February 9, 2016 1 / 20
OPEN ACCESS
Citation: Qian J, Nunez S, Reed E, Reilly MP,
Foulkes AS (2016) A Simple Test of Class-Level
Genetic Association Can Reveal Novel
Cardiometabolic Trait Loci. PLoS ONE 11(2):
e0148218. doi:10.1371/journal.pone.0148218
Editor: Chuhsing Kate Hsiao, National Taiwan
University, TAIWAN
Received: July 22, 2015
Accepted: January 14, 2016
Published: February 9, 2016
Copyright: © 2016 Qian et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All data were obtained








Funding: Support for this research is provided by
National Institutes of Health, National Heart, Lung
and Blood Institute R01-HL107196 (JQ, ER, SN,
Conclusions
We conclude that it would be prudent to include class-level testing as standard practice in
GWA analysis. GenCAT, for example, can be used as a simple, complementary and effi-
cient strategy for class-level testing that leverages existing data resources, requires only
summary level data in the form of test statistics, and adds significant value with respect to
its potential for identifying multiple novel and clinically relevant trait associations.
Introduction
Large-scale genome-wide association (GWA) meta-analyses have become routine practice for
discovery of the genetic underpinnings of complex traits, such as cardiometabolic disease
(CMD). Several resulting meta-analysis resources, including summary level information on
association between each of several million typed and imputed SNPs and a well-defined trait,
are now publicly available. At the same time, we see a growing number of classifications or tax-
onomies of the genome—for example, protein coding genes, epigenetic marks, enhancer ele-
ments and non-coding RNAs—herein referred to as classes. Additionally, we have refined
knowledge regarding the linkage-disequilibrium (LD) structure across the genome via the 1000
genomes project. In turn, this presents new opportunity to further potentiate the extensive,
existing data resources through application of theoretically sound methodological advance-
ments that integrate these multiple knowledge components. In this report, we leverage these
multiple existing knowledge resources to demonstrate the potential added value of applying a
class-level testing strategy to complement more routine analysis practice.
To illustrate the breadth of potential novel discoveries with class-level testing, we test for
protein-coding gene associations with 14 unique phenotypes across six publicly-available
meta-analysis summary level data resources focused on the genetic basis of complex CMD,
summarized in Fig 1. A confirmatory analysis is presented that leverages the multiple distinct
analysis phases involving expanded cohorts that are reported for both the Global Lipids Gen-
tics Consortium (GLGC) meta-analysis data [1, 2] and The Coronary ARtery DIsease
Genome-wide Replication And Meta-analysis (CARDIoGRAM) consortium data [3, 4], as
described in more detail in the methods section below. A discovery analysis uses the recently
expanded GLGC data (GLGC—2013) [2], the DIAbetes Genetics Replication And Meta-analy-
sis (DIAGRAMv3) consortium data [5, 6], the Genetic Investigation of ANthropometric Traits
(GIANT) consortium meta-analysis data [7–9] and Meta-Analyses of Glucose and Insulin-
related traits Consortium (MAGIC) meta-analysis data [10, 11]. Protein coding gene-level
associations with each of the 14 traits listed in Fig 1 are investigated. These public resources
represent the largest sets of genome wide data for traits and diseases that collectively are the
greatest source of morbidity and mortality worldwide. Using the single-element analysis proce-
dures, GWA studies have identified many novel loci for these traits, all with complex genetic
bases. Despite these large resources and substantial discoveries, the majority of the heritability
for several of these traits remains unexplained, highlighting the need for additional studies and
application of statistical methods to reveal more completely the genetic architecture of these
disease-related traits.
The testing framework we apply, termed Genetic Class Association Testing (GenCAT),
leverages the available meta-analysis results for each of the resources listed in Fig 1. These find-
ings include individual SNP-level test statistics of association based on combined output
from fitting generalized linear multivariable models for each SNP, adjusting for clinical and
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demographic information, in each of multiple data sets (numbers provided in Fig 1). GenCAT
is a simple extension of the previously described quadratic test (QT) and the versatile gene-
based association study (VEGAS) approach [12, 13]. Similar to the QT, GenCAT involves first
transforming normal variates using estimates of underlying within class correlation struc-
tures. The QT approach is based on inverse normally transformed p-values from SNP level
tests of the difference in allele frequencies between cases and controls, while we use test statis-
tics from generalized linear models fitted to binary and quantitative traits. This requires an
alternative formation of the associated covariance structure, as derived in Appendix A. Addi-
tionally we introduce a data reduction component that minimizes data redundancies, and
thus instabilities in the transformations, introduced by high degrees of within class correla-
tions. This approach incorporates the eigenvalues of the covariance matrix, a measure also
used in [14] and [15], but is principally different than these approaches, as discussed below.
This data transformation allows straightforward application of a theoretically derived test sta-
tistic distribution for formal hypothesis testing of individual class-level effects, rendering the
approach computationally efficient and thus markedly distinct from VEGAS which relies on
an empirically based testing strategy which is computationally more intensive, as illustrated in
the simulation section below.
A growing literature exists on gene and pathway-based approaches to GWA analysis (see
for example, [12, 13, 16–29]), each with unique attributes and notable, relative advantages
and disadvantages. These include methods specifically developed for rare-variant analysis
(which is not a focus of this manuscript), and methods that include use of raw genotype data as
well as those that leverage summary level data resources, as we do herein. The purpose of this
Fig 1. Summary of GWASmeta-analysis data resources. ¶Acronyms: The Coronary ARtery DIsease Genome-wide Replication And Meta-analysis
(CARDIoGRAM) consortium data; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) consortium data; The Genetic Investigation of
ANthropometric Traits (GIANT) consortium meta-analysis data; The Global Lipids Gentics Consortium (GLGC) meta-analysis data; and Meta-Analyses of
Glucose and Insulin-related traits Consortium (MAGIC) meta-analysis data. §The CARDioGRAM—2011 and GLGC—2010 summary data are used in the
phase one—discovery analysis as expanded resources based on larger numbers of individuals are now available to validate GenCAT “discoveries” using
these older data resources. The remaining data sets are used in the phase two—discovery analysis which yields the reported novel findings. *Total number
of typed and imputed SNPs in original data files available for download. **SNPs after filtering for HWE, MAF, call rate, belonging to a protein-coding gene
and in PennCATH HapMAP imputed data.
doi:10.1371/journal.pone.0148218.g001
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manuscript is not to provide a comprehensive comparison of these methods, discerning which
is most powerful under given alternatives; rather, we aim to (1) highlight the potential gains
from application of one gene-based strategy, namely GenCAT, when coupled with the com-
mon first-stage analysis that focuses on single SNP associations, termed minP; and (2) report
on a comprehensive application of this gene-based strategy to several large meta-analysis
resources involving CMD related traits. The minP approach to evaluating association between
protein coding genes and a trait is to ascribe SNPs with p-values less than a Bonferroni cor-
rected threshold to genes and to declare these genes statistically meaningful. Typically a
genome-wide significant threshold is set to be 5×10−8, which assumes roughly 1-million inde-
pendent signals across the genome. While the minP approach has led to a large number of
novel gene discoveries, it is limited in that a gene must contain at least one SNP with a very
large signal to be identified, and may not capture genes with multiple SNPs that have moderate
signals, which in combination are genetically, biologically, clinically, and statistically meaning-
ful. We focus on GenCAT as our testing strategy in particular because it is easy to implement
with existing data resources, computationally efficient and powerful under alternatives not well
captured by minP, as we illustrate in our simulation study, and extensible—e.g. we illustrate
the flexibility and efficiency of applying GenCAT in a pathway analysis. However, we acknowl-
edge that alternative methods may perform equally well or better under certain alternatives.
We consider the comparative computational efficiency of VEGAS [13] and the family-wise
error control of QT [12] in our simulation study. The overarching emphasis herein is on the
value of implementing a gene-level strategy as routine best practice for GWA analysis.
Methods
A class-level test statistic
Consider a class of size n and let z = (z1, z2, . . ., zn)
T be a vector of n test statistics (z-scores) for
association of each element in this class with the trait under study. For simplicity of notation
we suppress dependency on class. Typically, the elements of z are SNP-level Wald test statistics
arising from fitting multivariable models, where each model includes a single SNP term, as well
as several clinical and demographic variables. The vector z has a multivariate normal distribu-
tion, z* Nn(0, Ʃ), under the null of no association between any of the n elements in this class.
This assumption of normality is reasonable given the large sample sizes of the GWAmeta-
anlayses (see Fig 1). Because S is square and positive definite, we can decompose S as follows
using the eigenvalue decomposition, S ¼ QLQT, where Q is an orthogonal matrix (i.e.,
QTQ ¼ QQT ¼ I) whose columns are the eigenvectors (normalized to unit length) of S, and Λ
is a diagonal matrix with diagonal elements equal to the eigenvalues of S. We define the class-
level test statistic, Cs, as the sum of the squared transformed test statistics, Cs ¼ UTU , where
U ¼ L1=2QTz. We note that Cs can be expressed as Cs ¼ zTðL1=2QTÞTðL1=2QTÞz ¼ zTS1z
and the quadratic form, zTS1z, follows a central chi-squared distribution with n degrees of
freedom, i.e., χ2(n).
To calculate Cs, we replace the variance-covariance matrix of z-test statistics, S, with P
where the (r, s)-th component of P is Pearson’s correlation coefficient, ρxr, xs between SNPs r
and s. The related linkage disequilibrium (LD) structure based on phase known data, has been
applied previously without formal proof, as an estimate of the positive correlation between
SNP-level χ2-test statistics in genes (for example, [13, 15]). In our setting, we are interested in
positive and negative correlation of SNP-level z-test statistics in genes, in the context of multi-
variable modeling of additive genetic effects. In Appendix A, we provide a detailed derivation
for the equivalence under certain conditions of the pairwise correlation between the z-test sta-
tistics and the pairwise correlation between the SNP measures in the linear model framework.
A Simple Test of Class-Level Genetic Association
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While this derivation is more complex in the generalized linear model (GLM) setting, we com-
pleted a simulation study to show that the expected correlation between test statistics based on
a GLM with a logit link function is estimated by the observed SNP-level correlation. This
results is illustrated in S1 Fig, with simulation details provided in the corresponding figure leg-
end. Notably, use of pairwise SNP correlations to estimate the correlations of corresponding
test statistics in the GLM setting has been described and applied, (for example, [16]).
In the example herein, we are analyzing summary level data, and therefore S needs to be
estimated using an independent data set with raw genotype information. Selecting an appropri-
ate dataset with similar ancestry for estimation of S is imperative as use of a biased estimate of
S based on data derived from individuals with different racial or ethnic backgrounds could
lead to erroneous conclusions. In our example we use the PennCATH data for estimation of S.
PennCath is one of the core GWAS nested in CARDIoGRAM and serves as a representative
regional population with no admixture [3, 30]. We use bP to represent this estimate of S in
which pairwise correlations are estimated from a representative sample.
When S is close to singular resulting from a very high degree of correlation between at least
two test statistics, the transformed values U, and therefore the test statistic Cs can be unstable.
We eliminate redundancies arising from very high degrees of within class correlations using a
dimension reduction approach that relies on the eigenvalues of the covariance matrix. This
measure is also used in [14] and [15]; however, our approach is principally different because
rather than determining the effective number of tests using just these eigenvalues, we are map-
ping our full data onto a reduced dimensional space, defined by the eigenvectors that captures
a pre-specified proportion of the within class variability. Specifically, we project the vector
of test statistics onto the space defined by the minimum set of eigenvectors of S that capture
(1−ψ)% of the variability in S, where in our example we let ψ = 0.05. That is, let lð1Þ;    ; lðnÞ
represent the ordered eigenvalues of S (from largest to smallest) and qð1Þ;    ; qðnÞ the corre-
sponding eigenvectors normalized to unit length. We select K such that:








We define eL to be the sub-matrix of Λ with diagonal elements lð1Þ;    ; lðKÞ, and let eQ be
the sub-matrix of Q with columns qð1Þ;    ; qðKÞ. Finally, we let:eU ¼ eL1=2eQTz ð2Þ
and use this in place of U for our calculations of Cs where eU i is the ith element of eU . This data
reduction procedure serves ultimately to improve computational efficiency as well as stability
of our test statistics. A step-by-step summary of GenCAT is provided in Box 1.
Analysis approach
We begin with a phase 1—confirmatory analysis that aims to leverage the multiple phases of
data collection and resulting meta-analysis data resources and publications that are available
through both the GLGC and CARDIoGRAM consortia. This first stage validation analysis
involves applying GenCAT to early phase analysis results, specifically the 2010 GLGC findings
reported in [1] and the 2011 CARDIoGRAM findings reported in [3] (GLGC—2010 and CAR-
DIoGRAM—2011 in Fig 1), and then using expanded resources that are based on larger and
more recently reported cohort data [2–4] as a comparator for evaluating the performance of
GenCAT. While GenCAT is intended as a complementary strategy to minP, we expect true
A Simple Test of Class-Level Genetic Association
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GenCAT positive findings to be supported by minP positive results in larger data settings and
thus we consider this comparison. For GLGC, the expanded data resources used for validation
are available for direct interrogation (GLGC—2013 in Fig 1), while for CARDIoGRAM we rely
on published reports including an expanded replication study involving up to 56,682 additional
individuals, reported in [3], and a larger cohort study of 63,746 CAD cases and 130,681 con-
trols representing an expansion of the CARDIoGRAM—2011 data to include 34 additional
studies, reported in [4]. For both the GLGC—2010 and the original CARDIoGRAM—2011
studies, we report the numbers of novel GenCAT discoveries that are subsequently discovered
using minP in the expanded data resources involving substantially larger sample sizes. The
confirmatory analysis is intended to characterize the performance of GenCAT for identifying
protein-coding gene associations with CMD traits that are later discoverable (after additional
data collection) using standard analysis tools.
In a phase 2—discovery analysis, we apply GenCAT to 13 CMD related traits across four
GWAmeta-analysis resources (described in Fig 1). We report the total number of protein-cod-
ing genes that are GenCAT+, i.e. the number of gene-level test statistics, eCs  w2ðKÞ, with a
corresponding p-value less than 0.05/N, where N is the number of genes investigated for the
corresponding GWA study. Additionally, the numbers of these GenCAT discoveries that are
minP-, i.e. do not contain a single SNP p-value less than 5×10−8, are reported for each trait.
GenCAT+ genes in novel loci are defined as a subset of the GenCAT+/minP- genes that are
also not within a ±500Kb region of a minP+ gene. Finally, GenCAT+ novel gene findings
within a ±500Kb region are combined into novel loci and the total number of novel loci are
reported. We also provide detailed results, including gene names, coordinates, numbers of
Box 1: Summary of GenCAT approach (for each class).
1. Calculate eU of Eq (2) as follows:
a Compute the eigenvalues and eigenvectors of S. Let lð1Þ;    ; lðnÞ represent the
eigenvalues sorted from largest to smallest.
b Determine the minimum value of K such that the sum of n−K smallest eigenvalues
is less than ψ = 5% of the sum of all eigenvalues (Eq (1))
c Define the reduced matrices eL and eQ to include the largest K eigenvalues and corre-
sponding eigenvectors given in Λ and Q.
2. Calculate the class-level test statistic, Cs defined as the sum of squared transformed
test statistics: eC s ¼ eUT eU
and compare to a central chi-squared distribution with K degrees of freedom to deter-
mine an associated p-value.
3. Compare the p-value of step 2 to a Bonferroni adjusted threshold based on the total
number of classes.
A Simple Test of Class-Level Genetic Association
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SNPs, GenCAT statistic and p-value, and minimum single SNP p-value, for GenCAT+ genes
within GenCAT novel loci. We acknowledge that our discovery analysis does not interrogate
intergenic regions which are increasingly being annotated and recognized as containing highly
ordered regulatory elements that control expression and function of protein-coding genes and
in themselves can be actively transcribed molecules. We consider this further in the Discussion
below.
The input to our analysis is single SNP-level test statistics in the form of z-scores corre-
sponding to tests of additive association between single SNPs and a specified trait. These statis-
tics are previously derived from fitting generalized linear multivariable models in each of
multiple sub-studies and combing these in a meta-analysis. The CARDIoGRAM data, for
example, are the result of a meta-analysis of 86,995 individuals (22,233 cases and 64,762 con-
trols) across 22 GWA studies that tested trait association at a total of 2,420,350 genotyped and
imputed SNPs that span both protein coding genes as well as intergenic regions. We focus our
analysis on 989,932 SNPs that are located in 17,280 protein coding genes and present in the
PennCath cohort data [30]. PennCath is one of the 22 studies that is included in the CARDIo-
GRAM GWAmeta-analysis and we have direct access to delinked raw genotype data to allow
estimation of pairwise correlations between SNP level test statistics in this study as required to
derive the GenCAT test statistic. Thus the PennCATH data are used for estimating correlations
for each of the five meta-analysis resources. In addition to filtering SNPs in protein-coding
genes, we limit analysis to SNPs that, in the PennCath cohort, have a minor allele frequency
>0.01, a Hardy Weinberg equilibrium p-value<0.001, and a SNP call rate, defined as the pro-
portion of non-missing values,0.90. The total numbers of SNPs available, as well as the num-
bers after filtering, for each trait under study are provided in Fig 1.
A simulation study
We conduct a simulation study to characterize the performance of GenCAT with respect to the
family-wise error rate and power under a range of underlying conditions, with particular atten-
tion given to the relative performance of the commonly applied minP approach. Emphasis is
on the added value of GenCAT and not a comparison of the two approaches as gene-level test-
ing is intended to complement single-SNP analysis. Here the minP approach is defined in a
standard way as calling a gene statistically significant if the minimum single-SNP p-value in
the gene is less than a Bonferroni corrected threshold based on the total number of SNPs in the
study. In practice the minP analysis typically proceeds by analyzing each SNP individually, and
then ascribing genes post hoc to those SNPs that are statistically significant. We also highlight
the potential gains in computational efficiency compared to the Versatile Gene-Based Associa-
tion Study (VEGAS) approach, described by [13], which relies on simulation of the empirical
distribution for p-value calculations.
The simulation study is based a complete set of 17,280 genes and the observed number of
SNPs in the CARDIoGRAM consortium GWAmeta-analysis data [3] of transformed test sta-
tistics within these genes. Raw genotype data from the PennCath cohort [30] are used to
estimate the pairwise correlation between SNP-level test statistics as we have shown to be
appropriate in Appendix A. Here we limit consideration to genes with less than 100 SNPs for
computational purposes as we are repeating the simulation a large number of times; however,
GenCAT can accommodate classes with a large number of components. To begin, for each
gene i, we generate ki independent z-scores from aMVN(0, I) distribution, where ki is the num-
ber of SNPs in gene i after transformation using the PennCATH data to estimate the covari-
ance structure. We assume multivariate normality to emulate the real data setting in which we
have correlated, normally distributed test statistics. We calculate the GenCAT statistics eC s and
A Simple Test of Class-Level Genetic Association
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corresponding p-values and compare to the Bonferroni corrected threshold with an adjustment
based on 17,280 genes. This process is repeated 4000 times and we determine the proportion of
simulations that result in at least one significant gene finding (p-value<0.05/17280). These
proportions serve as our estimates of the family-wise error rates under the complete null
(FWEC).
Power in our setting is defined as the probability of detecting a single gene generated under
the alternative. To determine empirical power, we first randomly select a gene i and generate ni
independent normals. Here we assume a pre-specified percentage, referred to as the “percent-
age partial signal”, arise from aMVNðm1ni ; IniÞ and the remaining arise from aMVNð0; IniÞ,
where ni is the number of observed SNPs in gene i. Calling these statistics x1i and x
2
i and using
the estimated correlation structure, bPi from the PennCATH data, we then transform xi ¼
ðx1i ; x2i ÞT by pre-multiplying by QiL1=2i , where bPi ¼ QiLQTi , Qi is an orthogonal matrix whose
columns are the eigenvectors (normalized to unit length) of bPi, and Λi is a diagonal matrix with
diagonal elements equal to the eigenvalues of bPi. Formally, we have ex i ¼ QiL1=2i xi andexi  MVNðem i; bPiÞ. These are treated as the observed data to which we apply GenCAT and
record whether the gene is correctly selected, based on the Bonferroni corrected threshold of
0.05/17,280. Power is calculated assuming full signal for a range of μ from 2 to 6, and under
partial signals of 0.1 to 0.9 for μ = 4.0. For each value of μ, and percentage partial signal, we
conduct 2000 simulations, and power is defined as the proportion of the 2000 simulations that
correctly detect association. Power is reported for eC s as well as minP under the same conditions
to characterize the potential contribution of a gene level testing strategy.
Finally, we determine the computational time for running VEGAS and GenCAT. Recall,
VEGAS similarly defines a gene-level test statistic based on the sum of untransformed χ2 statis-
tics in each gene; however, to determine statistical significance of each gene, the VEGAS
approach requires the generation of new data—between 103 and 107 simulations—with the
same correlation structure as the observed data and under the null model. The number of sim-
ulations for each depends on: (a) the total number of genes under study and (b) the level of sig-
nificance of the specific gene being tested. So for example, a gene that is not significant
(p> 0.10) will require 103 simulations regardless of the total number of genes under study. On
the other hand, a gene that has a p-value<10−7, will require 103 simulations if it is the only
gene being tested, but will require at least 107 simulations if more than 10,000 genes are being
considered to achieve appropriate precision.
To illustrate and contrast the computational time of each approach, we begin by considering
the analysis time for each of two genes, Lipoprotein, Lp(A) (LPA) and Proline/Serine-Rich
Coiled-Coil 1 (PSRC1) with 67 and 5 SNPs respectively, both highly significant based on minP
and the Cs statistic (results not shown) in CARDIoGRAM. For this study, we vary the assumed
total number of genes under study from one to 10,000 and report the central processing unit
(CPU)-time for analyzing just the single gene, using R on a single Intel Core i7-3520M CPU @
2.90GHz. We also report the expected CPU-time for analysis of a complete set of 19,018 genes
for an assumed range of between approximately 0.1% and 2.0% of genes with a p-value that is
less than the Bonferroni corrected threshold.
Available software
Analysis is performed using the GenCAT() function of the GenCAT package ver 1.0.1 in R
(http://cran.r-project.org/web/packages/GenCAT/index.html). This function requires a data
table with a row for each each SNP and columns corresponding to SNP name (e.g. rs number),
SNP-level test statistic, chromosome number, class assignment, effect allele and other allele.
A Simple Test of Class-Level Genetic Association
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Raw genotype data in the form of a SnpMatrix object is also required for estimation of the
covariance. The resulting object includes several data frames, containing information on Gen-
CAT test results, the SNPs used in analysis and transformed test statistics. The Manhattan plot
is generated using the GenCAT_manhattan() function, also available in the GenCAT
package.
Results
Applications to CMD traits in GWAmeta-analysis resources
Findings of the phase 1—confirmatory analysis. A summary of the phase 1—confirmatory
analysis findings is provided in the top half of Fig 2. In total, GenCAT identifies six novel loci
for CAD using the available CARDIoGRAMmeta-analysis summary data (see S1 Table for
details). Five of these loci—labelled, ABO, MYL2, Collagen, Type IV, Alpha 1 (COL4A1),
HHIP-Like 1 (HHIPL1) and ADAMTS7—are confirmed findings based on minP using
expanded data resources [3, 4], while one of the GenCAT significant loci—Dual Specificity
Phosphatase 26 (DUSP26)—is not reported as significant in follow-up analysis. Further investi-
gation and validation of DUSP26 is required to confirm whether or not this represents a false
finding. GenCAT analysis of the GLGC—2010 data suggests 28 novel loci, of which 23 are con-
firmed as minP+ using the expanded GLGC—2013 data resource (see S1 Table for details).
Overall, these findings are consistent with our power calculations suggesting that GenCAT can
detect associated loci with less data than minP in some circumstances. Or stated differently,
here GenCAT finds trait associations with loci in smaller datasets and these associations are sub-
sequently confirmed using the minP approach in much larger GWA datasets for the same traits.
Findings of the phase 2—discovery analysis. A summary of GenCAT findings across the
13 traits in the phase 2—discovery analysis are reported in the bottom half of Fig 2, with specific
details provided in S2–S5 Tables. As GenCAT is intended to complement minP, we focus on
the number of genes that were not detected by minP and are also not within 500Kb of a gene
that is detected by minP. In total, GenCAT identifies 54 such genes, and these are mapped to
41 distinct loci (i.e., 41 regions that are not within 500Kb of one another.) Consistent with our
expectation, the most discoveries are made in the large GIANT dataset for height, which is a
highly genetic trait, while contributions, above and beyond minP significant loci, are present in
ten of thirteen analyses. Further interrogation of these loci, as with any finding from a GWA
analysis, is required for confirmation and validation.
A visual representation of the findings for the CARDIoGRAM analysis is provided in Fig 3.
In this Manhattan style plot, the x-axis corresponds to location on the genome and the y-axis is
the negative log of the GenCAT p-value. Each dot represents a gene and the horizontal line
indicates the adjusted significance threshold. GenCAT positive genes that are minP negative
(in green) and denoted with a  are within a 1Mb (±500Kb) region of a minP positive gene and
are therefore not considered novel GenCAT findings. All of these genes, with the exception of
DUP26, are confirmed findings as they are within minP positive regions in subsequent analysis
that uses additional data. Additional details on minP significant genes are available in the pri-
mary analysis reports [1–3, 7–9].
Finally, in Fig 4(a) we illustrate the observed GenCAT gene-level test statistics based on
CARDIoGRAM CAD as compared to the expected quantiles of a χ2-distribution. As each sta-
tistic has degrees of freedom equal to the number of transformed test statistics, we limit this
plot to genes with the median number of 5 statistics after transformation. The expected χ2-dis-
tribution is also based on 5 degrees of freedom. For the purpose comparison, Fig 4(b) illustrates
a similar quantile-quantile plot based on the observed GenCAT test statistics based on MAGIC
insulin resistance, a trait that resulted in no minP positive or GenCAT positive findings. As
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expected, the observed test statistics for MAGIC insulin resistance are closer than the CARDIo-
GRAM CAD statistics to the (y = x)-line.
Pathway analysis using GenCAT. As an additional illustration of the versatility of GenCAT
to alternative class-level taxonomies, we applied it to 50 hallmark gene sets in the Molecular
Fig 2. Summary of GenCAT discoveries in GWAmeta-analysis data resources. *Number of genes detected by GenCAT that do not include a single
SNP with a p-value less than the Bonferroni threshold of 5×10−8. **Number of genes/loci detected by GenCAT that are not within 500Kb of a gene that
contains a single SNP with a p-value less than the Bonferroni threshold using the available GWA data. x Twenty-seven of 34 loci detected by GenCAT in
CARDIoGRAM-2011 and GLGC-2010 were reported in follow-up analysis using minP with substantially more data [2–4]. These are therefore not novel
findings given later publications, but highlight the ability of GenCAT to identify genes that are ultimately discoverable (“validated”) with minP when
substantially larger datasets are interrogated.
doi:10.1371/journal.pone.0148218.g002
Fig 3. Manhattan plot illustrating GenCAT andminP protein-coding gene discoveries using CARDIoGRAMmeta-analysis data. The horizontal line
indicates the Bonferroni corrected threshold of 0.05/17280 = 2.89×10−06. Genes indicated with * are significant for GenCAT and negative for minP
(GenCAT+/minP-) but are within 500Kb of a minP significant gene.
doi:10.1371/journal.pone.0148218.g003
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Signatures Database (MSigDB) representing well-defined biological processes (http://www.
broadinstitute.org/gsea/msigdb/collections.jsp#H) using the CARDIoGRAM data. Here classes
are defined as gene sets, and thus we are testing the association of each gene set with the pheno-
type. For example, we test for association between CAD and the Hallmark Interferon Alpha
Response gene set, which is defined as a set of 97 genes (88 genes for which we have available
data) that are up-reguated in response to alpha interferon proteins. GenCAT identified 25 of the
50 hallmark gene sets as associated with CAD. The distribution of numbers of genes and SNPs
within these sets, as well as Cs and the minimum single SNP p-values, are provided in S6 Table.
Although there is likely overlap between gene sets (i.e., the same genes/SNPs will belong to mul-
tiple gene sets), we apply a Bonferroni corrected threshold based on the 50 sets considered,
which we expect to be conservative. Also included in this table is the strongest gene signal within
the corresponding gene set (based on minP) and whether the minimum p-value within this gene
is less than a Bonferroni corrected significance threshold based on the number of SNPs (n) in
the gene set.
These illustrative pathway analyses are informative in revealing many expected associations,
including for example the “bile acid metabolism”, “cholesterol homeostasis”, “coagulation”,
“complement” and “DNA repair” gene sets with CAD while suggesting novel relations of CAD
with inflammatory (“interferon alpha resp”) and metabolic signaling (“PI3K_AKT_MTOR”)
pathways. A broad assortment of sophisticated analytic methods have been described for gene
set enrichment analysis (for example, [22–26]) and a formal and comprehensive comparison
beyond our illustrative scope here would elucidate the relative advantages and disadvantages of
GenCAT in this setting. Here we aim only to illustrate that the analysis of gene sets is one addi-
tional application of GenCAT that can be easily and efficiently applied to GWA summary data
Fig 4. QQ plots of observed versus expected GenCAT test statistics.
doi:10.1371/journal.pone.0148218.g004
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to further enhance their biological and clinical translation. Further alternative application set-
tings are discussed below.
Simulation study findings
The estimated FWEC based on 4000 simulations is 0.043 for Cs, the expected nominal level.
The estimated FWEC for minP is 0.016, smaller than the nominal level, which is expected in
the context of dependencies because the Bonferroni correction only ensures an upper bound
for the FWEC. For comparison, we additionally estimate the FWEC based on a modified QT
[12] in which we use Pearson’s correlation between SNPs as the estimated correlation between
corresponding test statistics. We note that QT was developed in the context of case control
data and in that setting, an alternative estimate of the covariance was applied; however, we
expect both estimates to be unbiased. In this case, GenCAT and QT are equivalent with the
exception that GenCAT includes a data reduction step as described by Eqs 1 and 2. The FWEC
based on 1000 additional simulations, and in this case limiting analysis to testing 100 genes
each with less than 20 SNPs for computational purposes, is estimated to be 45.3% for QT and
5.5% for GenCAT using a Bonferonni correction for 100 tests.
The type-1 error rate (based on testing a single gene), on the hand, is close to the nominal
level of 0.05 (0.057 for QT and 0.051 for GenCAT). This is a result of the covariance matrix of
test statistics being close to singular, and in turn, the tendency of QT to over estimate the gene-
level test statistics, resulting in a lack of p-value precision for QT. This instability is addressed
with GenCAT through the data projection step which is why GenCAT has appropriate control
of the FWEC. We additionally considered the power of QT and GenCAT in this single gene
testing setting in which error is appropriately controlled. Notably, in our application of Gen-
CAT we set ψ = 0.05, and as described above, QT is equivalent to GenCAT with ψ = 0. While
the two approaches are comparable for shift parameters of μ = 3.0 and greater (power>98%
for both approaches), QT consistently performs better than GenCAT for more moderate sig-
nals of μ = 1 and 2 (empirical power = 64.6% and 96.1%, respectively, for QT and empirical
power = 33.7% and 88.2%, respectively, for GenCAT). Importantly, in the GWAmultiple test-
ing setting that we are interested in, QT has inflated FWEC as we have shown in simulations,
and thus it is not meaningful in this context to compare the power of QT to that of GenCAT.
Empirical-based power estimates under a range of conditions are reported and illustrated in
Fig 5(a) and 5(b). For computational and practical purposes, we focus the power analysis on
genes with less than 100 SNPs and the partial signal analysis additionally excludes genes with
only a single SNP. Here we see that if the mean of the element-level test statistics in a class is at
least 4.0 and we assume a full signal—i.e. all element-level (single SNP-level) test statistics in
the class (gene) arise from a distribution with this mean—then we expect to achieve 80% power
to detect the class using the Cs statistic (Fig 5(a)). On the other hand, under the same condi-
tions, we achieve 63.5% power with the minP approach (Fig 5(a)). Power of the minP approach
approaches the power of Cs when μ 6.0. These results are consistent with our expectation
that Cs would complement minP in the case of moderate signal across multiple elements in a
class.
As expected, and illustrated in Fig 5(b), power decreases when we eliminate a percentage of
the elements that have a signal, that is, when less than 100% of the element-level test statistics
in a class arise from a distribution with non-zero mean. Under partial signal scenarios Cs is
consistently about 21% more powerful than minP. While we can not observe the true percent-
age signal to determine what is most reasonable to assume, our real data analysis results in sub-
stantially more findings using the combination of minP and GenCAT than found by minP
which is consistent with this observed increase in power under all scenarios for partial signal.
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Fig 5. Simulation study results. *We also adjust the p-value distribution to reflect the observed distributions (i.e. estimated proportion of genes for which
p 2.6×10−6; 2.6×10−6 < p 0.001; 0.001 < p 0.1; and 0.1 < p) for two complementary data settings: (1) CARDIoGRAMwith CAD as the outcome where
the estimated proportions are 0.001262, 0.007151, 0.1394 and 0.8521; and (2) GIANT with height, a well-described and highly genetic trait—results not
shown, as the outcome where the estimated proportions are 0.01670, 0.02667; 0.1539, and 0.8027. Linear extrapolation is applied to estimate times in
between these two extremes in Fig 5(d).
doi:10.1371/journal.pone.0148218.g005
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The computational times for implementing GenCAT and VEGAS for a range of conditions
are illustrated in Fig 5(c) and 5(d). As shown by the red horizontal line of Fig 5(c), the compu-
tational burden associated with the GenCAT analysis of a single gene (whether or not it is
statistically meaningful) is not influenced by the total number of genes under study. The
computational time associated with VEGAS, on the other hand, for the analysis of a statistically
meaningful gene, increases with the total number of genes under investigation. This is a direct
result of the VEGAS requirement of more simulations as the Bonferroni corrected threshold
for statistical significance is lowered (i.e. when the number of genes under study is increased.)
Moreover, this increase in computational burden is greater for larger genes, as illustrated for
LPA with 67 SNPs compared to PSRC1 with five SNPs.
In Fig 5(d), we similarly see that the computational time associated with GenCAT analysis
of a full set of 19,018 genes is independent of the percentage of significant genes and is rela-
tively constant as the size of the genes under study increases. The computational time for
VEGAS, on the other hand, in this setting, increases as the percentage of Bonferroni significant
genes increases from 0.0025 to 0.020. Fig 5(d) includes a very approximate range of computa-
tional times (shaded region) where the lower bound is based on all genes composed of five
SNPs while the upper bound is based on all genes consisting of 67 SNPs. As described in Fig 1,
for the three studies we investigate, a plausible range for the number of SNPs in a gene is one to
about 5,500 with a mean of approximately 60 and a median of 22−24. The computational times
illustrated in Fig 5(d) for both VEGAS and GenCAT are not intended to be highly precise;
rather this figure illustrates their relative computational burden under the more extreme
scenarios.
Finally, we consider the sensitivity of GenCAT to choice of covariance structure. Herein we
focus again on the LPA gene and estimate type-1 error rates and power when data are gener-
ated assuming the PennCATH correlation structure for this gene and then analyzed using the
GenCAT approach with an estimated correlation structure based on (i) the original Penn-
CATH data; (ii) 1000 Genomes Caucasians (CEU) data; (iii) 1000 Genomes African Americans
(ACB) data; (iv) assuming independence. The third and fourth scenarios are clear mispecifica-
tions of the covariance matrix while the first scenario is the correct covariance and the second
scenario captures sampling variability. Based on 1000 simulations under the null of no associa-
tion, type-1 error estimates are 0.055, 0.050, 0.075 and 0.222, respectively. Power for detecting
shifts of 1, 2 and 3 is estimated to be 48.4%, 99.1% and 100%, respectively, for scenario 1, and
slightly lower at 40.8%, 97.9% and 100%, respectively, for scenario 2, and 38.6%, 98.3% and
100%, respectively, for scenario 3. Due to the inflation of type-1-error, the power of scenario 4
is not meaningful and thus not reported.
Discussion
In this manuscript we presented an approach for analyzing genetic classes that leverages exist-
ing data resources, including summary level findings from GWAmeta-analysis and knowledge
of underlying genetic structure. Our simulations studies suggested that GenCAT can comple-
ment the standard post-hoc identification of loci that is based on ascribing genes or loci to
statistically significant SNPs. We also demonstrate in our simulation study that use of our theo-
retically derived test statistic distribution is computationally more efficient than the empirical,
simulation based approach that is applied in VEGAS to approximate the theoretical distribu-
tion of the test statistic under the null of no association. Given the large number of classes typi-
cally under investigation (between 17,280 and 17,406 protein coding genes in the examples
provided), precise estimation of the corresponding p-values using empirical distributions
requires a large number of simulations, which is computationally burdensome. VEGAS uses a
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threshold for statistical significance and reports whether each class-level p-value is expected to
be above or below the threshold. The GenCAT approach, on the other hand, because it uses a
theoretically derived test statistic distribution, allows us to report an accurate quantitative p-
value while being computationally efficient. Such a framework also provides a foundation on
which to build theoretically rigorous extensions. For example, we are currently investigating
modifications to the data transformation step to test gene-environment interactions using sta-
tistics corresponding to tests of single SNP-environment interactions in multivariable models.
In addition to investigating protein coding genes, GenCAT can be applied to any of a num-
ber of class-level mappings in the pipeline, including for example, epigenetic marks, enhancer
elements and non-coding RNAs. Furthermore, SNPs might belong to multiple classes, for
example, both a protein coding gene and a non-coding RNA, or both a protein coding gene
and an intronic enhancer region. Thus, post-hoc ascribing of statistically significant SNPs to a
protein coding gene may be misleading in that the true mechanisms may be via a nested or
overlapping non-coding RNA or regulatory element. Indeed, approximately one third of all
non-coding RNAs have been identified that overlap with protein coding genes [31, 32]. Analy-
sis of class-level associations thus may better reflect the underlying associations. At the same
time, as with any association analysis, translation of any findings requires additional genomic
and functional analysis to identify the actual functional element at the locus. A variety of fol-
low-up approaches are typically employed at this stage, including, for example: fine mapping,
dense SNP genotyping or DNA sequencing which are used to localize the strongest trait associ-
ated SNP in the region; transcriptomics, which examines tissue expression of RNA molecules
and facilitates drawing connections between trait associated DNA elements and specific
expressed RNAs (e.g. via expression quantitative trait loci or allele specific expression); and
functional studies in cell systems and mouse models.
A notable limitation of GenCAT is the relatively low power associated with partial signals in
a class, as seen in Fig 5(b). While minP continues to maintain a good portion of its power for
detecting classes with at least one very strong signal, it performs relatively poorly in the context
of only moderate effects, as shown for μ< 4 in Fig 5(a). We are currently developing an exten-
sion of GenCAT that allows for testing whether the tail of the test-statistic distribution, e.g. the
most extreme 10% of element-level test statistics in a class, is different than we would expect
under a null of no association of the class. An additional limitation of GenCAT is that it does
not leverage information across all of the classes in making inference about a single class. We
described a mixed modeling framework in earlier work [27] that draws strength from the total-
ity of the data to make inference about each gene in a candidate gene setting; however, the rela-
tively small percentage of signal in GWA studies (e.g., 1% of protein coding genes) results in
insufficient variability in random class-level effects for straightforward application of this
mixed modeling framework to the setting described herein. Finally, apparent false negatives
may occur because our current application excludes intergenic regions where approximately
half of single SNP signals for some complex traits are found; such intergenic effects can be
detected and advanced more efficiently to functional studies through interrogation of specific
classes of intergenic regulatory features, such as non-coding RNAs or enhancers. Nonetheless,
our investigation suggests that GenCAT may add value to single element association testing
when we have moderate signal across the majority of elements in a class. Thus, in summary, we
emphasize that GenCAT may serve as a complementary strategy for identifying potentially
novel genetic loci, in the forms of specific classes e.g., protein coding genes, non coding RNA,
or gene sets or pathways, associated with complex traits.
Our research highlights the importance of routine application of a class-based testing strat-
egy for GWA analysis to complement more standard single-point testing and post-hoc ascrib-
ing SNPs to genes and loci. GenCAT is one of an expanding class of analytic methods designed
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specifically to uncover association in a manner that leverages known structure, e.g. SNP anno-
tations to protein coding genes and the local LD patterns across the genome. We demonstrate
that GenCAT is a simple, complementary and efficient strategy for class-level testing that
advances existing summary level data resources, and adds significant value with respect to its
potential for identifying multiple novel and clinically relevant trait associations.
Appendix A
GWA studies typically involve fitting a separate linear model for each element j (e.g., SNP j)
under investigation, given in a general form by:
yi ¼ b0 þ bjxij þ gvi þ i
where i = 1, . . .,m represents individual, xij is commonly coded as 0,1 or 2 for the number of
variant alleles observed for the jth element in individual i and vi represents some additional
clinical or demographic variable for individual i. For the ease of presentation, we assume vi to
be a scalar, but it is straightforward to extend the model to the scenario of multiple additional
clinical or demographic variables. Also, we assume i* N(0, σ
2). We can rewrite this model as:
yi ¼ a0 þ bjðxij  xjÞ þ gðvi  vÞ þ i
where a0 ¼ b0 þ bjxj þ gv . Now let xij;c ¼ ðxij  xjÞ and vi;c ¼ ðvi  vÞ be centered predictors,
and xjc ¼ ðx1j;c; :::; xmj;cÞT and vc ¼ ðv1;c; :::; vm;cÞT be the corresponding vectors containing all
i ¼ 1;    ;m individuals. Further define y ¼ ðy1;    ; ymÞT , 1m as anm-dimensional column of
1’s, Im asm ×m identity matrix, Dc ¼ ð1m;vcÞ andM ¼ DcðDTc DcÞ1DTc to be the orthogonal
projection operator onto Dc. We then have the estimated regression coefficient for the j-th ele-
ment and its variance as:
bb j ¼ xTjcðIm MÞxjch i1xTjcðIm MÞy;
and
Varðbb jÞ ¼ xTjcðIm MÞxjch i1s2:
Thus, given the usually large number of individualsm in genome-wide association studies,
the test statistic of the significance of bb j for the j-th element is a z-score,
zj ¼
bbjffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Varðbb jÞq ¼ s1 xTjcðIm MÞxjc
h i1=2
xTjcðIm MÞy:
Finally, under the assumption that xjc ? vc, i.e., the j-th element xj is independent of v, we
have:
zj ¼ s1 xTjcxjc
h i1=2
xTjcy:
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This assumption, that the covariates are independent of the genotype, is reasonable for the
applications we consider. Therefore, for any two elements, j and k, we can write:










h i1=2 ¼ rxj ;xk ;
where ρxj, xk the (j, k)-th component of sample Pearson’s correlation coefficient matrix, P, for
elements j, k 2 {1, . . ., n} within a class. Thus, we have shown that the variance-covariance
matrix of n test statistics z = (z1, z2, . . ., zn)
T in Section 3.1, S, is given by the sample Pearson’s
correlation coefficient P.
Supporting Information
S1 Table. Findings of phase 1—confirmatory analysis. Locus name is defined arbitrarily
based on observed genes in the locus, start and stop are the start and stop coordinates respec-
tively based on Genome Reference Consortium human genome (hg) build 37, n is the number
of observed SNPs in the corresponding gene, K is the number of SNPs after dimension reduc-
tion, Cs is the GenCAT Cs statistic, Cs_p is the corresponding unadjusted p-value, rs_minP is
the name of the SNP with the smallest p-value in the corresponding gene, and minP is the min-
imum observed p-value in the corresponding gene.
(TIF)
S2 Table. Summary of GenCAT discoveries in GIANT. Locus name is defined arbitrarily
based on observed genes in the locus, start and stop are the start and stop coordinates respec-
tively based on Genome Reference Consortium human genome (hg) build 37, n is the number
of observed SNPs in the corresponding gene, K is the number of SNPs after dimension reduc-
tion, Cs is the GenCAT Cs statistic, Cs_p is the corresponding unadjusted p-value, rs_minP is
the name of the SNP with the smallest p-value in the corresponding gene, and minP is the min-
imum observed p-value in the corresponding gene.
(TIF)
S3 Table. Summary of GenCAT discoveries in DIAGRAM—T2D. Locus name is defined
arbitrarily based on observed genes in the locus, start and stop are the start and stop coordi-
nates respectively based on Genome Reference Consortium human genome (hg) build 37, n is
the number of observed SNPs in the corresponding gene, K is the number of SNPs after dimen-
sion reduction, Cs is the GenCAT Cs statistic, Cs_p is the corresponding unadjusted p-value,
rs_minP is the name of the SNP with the smallest p-value in the corresponding gene, and minP
is the minimum observed p-value in the corresponding gene.
(TIF)
S4 Table. Summary of GenCAT discoveries in GLGC—2013. Locus name is defined arbi-
trarily based on observed genes in the locus, start and stop are the start and stop coordinates
respectively based on Genome Reference Consortium human genome (hg) build 37, n is the
number of observed SNPs in the corresponding gene, K is the number of SNPs after dimension
reduction, Cs is the GenCAT Cs statistic, Cs_p is the corresponding unadjusted p-value,
rs_minP is the name of the SNP with the smallest p-value in the corresponding gene, and minP
is the minimum observed p-value in the corresponding gene.
(TIF)
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S5 Table. Summary of GenCAT discoveries in MAGIC. Locus name is defined arbitrarily
based on observed genes in the locus, start and stop are the start and stop coordinates respec-
tively based on Genome Reference Consortium human genome (hg) build 37, n is the number
of observed SNPs in the corresponding gene, K is the number of SNPs after dimension reduc-
tion, Cs is the GenCAT Cs statistic, Cs_p is the corresponding unadjusted p-value, rs_minP is
the name of the SNP with the smallest p-value in the corresponding gene, and minP is the min-
imum observed p-value in the corresponding gene.
(TIF)
S6 Table. Summary of GenCAT discoveries of hallmark gene sets in CARDIoGRAM.
Twenty-five of 50 hallmark gene sets, defined in the Molecular Signatures Database (MSigDB)
(http://www.broadinstitute.org/gsea/msigdb/collections.jsp#H), are detected by GenCAT.
Number of genes in set with at least one available SNP, n is the number of observed SNPs in
the corresponding gene set, K is the number of SNPs after dimension reduction, Cs is the Gen-
CAT Cs statistic and Cs_p is the corresponding unadjusted p-value. §Strongest gene signal in
the gene set is based on minP.
(TIF)
S1 Fig. Simulation to estimate correlation of test statistics in GLM setting. A simulation study
was conducted to estimate the pairwise correlation between test statistics based on a generalized
linear model (GLM) with a logit link. The PennCATH data for 22 observed SNPs in the
ADAMTS7 gene were used for illustration. Pairwise Pearson correlations were calculated between
each SNP and rs2277547, the SNP with the minimum p-value in ADAMTS7 (shown on the x-
axis). For each pair of SNPs, 1400 data points were simulated according to a GLMwith a logit link
assuming an additive model between each of two SNPs (rs2277547 and one other) and model
coefficients of 0.2 and 0.4, respectively. In each case, separate GLMs were then fitted for each SNP
to mimic the true analysis approach and corresponding SNP level test statistics were recorded.
This simulation was repeated 100 times, each time recording the two SNP level test statistics. The
pairwise correlation was then estimated using Pearson’s correlation coefficient. This was repeated
for all pairs of SNPs. Finally, the entire procedure was repeated 100 times and the mean correla-
tion and 98% interval (shown on the y-axis) was determined for each pair of SNPs. This is plotted
against the original pairwise SNP correlations. This result suggests that, in this setting, Pearson’s
correlation coefficient between pairs of SNPs is a reasonable estimate of the correlation between
pairs of test statistics. We note that this estimate is commonly used in practice, e.g. [13, 16].
(TIF)
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